Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

BACKGROUND: Uveal melanoma (UM) is the most common intraocular malignancy in adults. In contrast to cutaneous melanoma (CM), there is no standard therapy, and the efficacy and safety of dual checkpoint blockade with nivolumab and ipilimumab is not well defined. METHODS: We conducted a retrospective...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Najjar, Yana G, Navrazhina, Kristina, Ding, Fei, Bhatia, Roma, Tsai, Katy, Abbate, Kelly, Durden, Barbara, Eroglu, Zeynep, Bhatia, Shailender, Park, Song, Chowdhary, Akansha, Chandra, Sunandana, Kennedy, Jonathan, Puzanov, Igor, Ernstoff, Marc, Vachhani, Pankit, Drabick, Joseph, Singh, Arun, Xu, Tan, Yang, Jessica, Carvajal, Richard, Manson, Daniel, M Kirkwood, John, Cohen, Justine, Sullivan, Ryan, Johnson, Douglas, Funchain, Pauline, Shoushtari, Alexander
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2020
Subjects:
Clinical/Translational Cancer Immunotherapy
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319717/
https://ncbi.nlm.nih.gov/pubmed/32581057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000331
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items